Wall Street’s main indexes closed lower on Friday, with the S&P 500 and Nasdaq notching their biggest one-day losses in two weeks, on concerns about slower interest-rate cuts and as …
The second quarter earnings season is underway and as many as 173 companies will announce their quarterly numbers for the July-September 2024 period today. Key results to watch out include …
By Nicole Ireland and Hannah Alberga The Canadian Press Posted September 24, 2024 12:40 pm 1 min read Descrease article font size Increase article font size Health Canada has approved …
Kansas AG Kris Kobach: Pfizer violated state Consumer Protection Act Pfizer: Case has ‘no merit’ and company will respond in ‘due course’ Dr. John Moore: Political vaccine misinformation deadly to …
(NewsNation) — The state of Kansas has sued the pharmaceutical company Pfizer, accusing it of misleading the public about its COVID-19 vaccine by making false claims about its effectiveness. In the …
“In North America, Revlimid is the key contributor and again, speciality drugs for Zydus Lifesciences that will keep on increasing EBITDA margins towards 29-30% and also in the valuation-wise Zydus …
Descrease article font size Increase article font size Pfizer on Wednesday forecast 2024 sales that were as much as $5 billion below Wall Street expectations due mostly to declining demand …
NEW YORK: U.S. stocks rallied and the S&P registered its highest close of the year on Friday, starting December on an upbeat note as remarks from Federal Reserve Chair Jerome …
Moderna should hit the lower end of its sales target for this year as it only needs to tap a small portion of the private market with its COVID vaccine to …
Pfizer on Tuesday urged investors to focus on growth in its non-COVID products such as its new RSV vaccine Abrysvo, after weak demand for its COVID-19 vaccine and treatment pushed …